All sites C00-96,D32-33,D42-43,D45-47,D76 894 88.7 4.1 3.5 1.0 2.7
Mouth, pharynx C00-14 12 98.4 - 1.6 - -
  Lip C00 2 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 2 90.0 - 10.0 - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 160 77.5 6.9 10.1 2.0 3.5
  Oesophagus C15 3 88.2 5.9 - 5.9 -
  Stomach C16 16 93.7 1.3 1.3 2.5 1.3
  Small intestine C17 4 100.0 - - - -
  Colon C18 54 91.5 0.4 4.1 1.8 2.2
  Rectum, rectosigmoid C19-20 20 96.9 - 1.0 - 2.0
  Anus C21 2 100.0 - - - -
  Liver C22 14 70.4 9.9 14.1 - 5.6
  Gallbladder, bile ducts C23-24 11 50.0 20.4 22.2 1.9 5.6
  Pancreas C25 30 42.3 22.1 26.8 2.0 6.7
  Other digestive organs C26 6 56.7 3.3 20.0 13.3 6.7
Respiratory organs C30-39 52 58.8 22.5 10.3 3.4 5.0
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 49 56.7 23.9 10.5 3.6 5.3
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 24 99.2 0.8 - - -
Skin, non-melanoma C44 41 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 7 100.0 - - - -
Breast C50 273 98.9 0.5 0.2 0.1 0.2
Female genital organs C51-58 104 93.7 2.1 1.7 1.0 1.5
  Cervix uteri C53 10 96.0 2.0 - 2.0 -
  Corpus uteri C54 49 98.8 0.4 0.4 - 0.4
  Uterus, other C55,C58 1 16.7 16.7 33.3 - 33.3
  Ovary C56 30 87.8 4.7 2.7 2.7 2.0
  Other female genital C51-52,C57 14 93.0 1.4 2.8 - 2.8
Urinary organs C64-68 40 92.0 2.5 3.5 - 2.0
  Kidney C64 25 90.2 3.3 4.1 - 2.4
  Bladder and urinary tract2 C65-68 15 94.7 1.3 2.6 - 1.3
Eye C69 1 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 36 85.7 - 7.1 - 7.1
Thyroid gland C73 41 96.6 2.9 - 0.5 -
Other endocrine glands C74-75 1 83.3 - - - 16.7
Illdefined or unknown C76,C80 19 53.7 17.9 9.5 8.4 10.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 79 81.5 5.8 1.5 0.8 10.4
  Hodgkin lymphoma C81 4 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 33 98.2 - - 0.6 1.2
  Malignant immunoproliferative diseases C88 1 66.7 - - - 33.3
  Myeloma and other plasma cell tumors C90 14 68.6 7.1 5.7 1.4 17.1
  Leukaemia C91-95 20 74.7 15.2 1.0 1.0 8.1
  Myelodysplastic syndromes D46 3 42.9 21.4 7.1 - 28.6
  Myeloproliferaitive neoplasms D45,D47 4 33.3 - - - 66.7
Not included above
  Carcinoma in situ of the breast D05 29 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 106 100.0 - - - -
  Borderline tumour of the ovary D39 9 97.8 - - - 2.2
  Basal cell carcinoma of the skin 264 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.